MedTrace Logo

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

NCT00822263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2010-08-10

No results posted yet for this study

Summary

The administration of N-acetyl-cysteine (an anti-oxidant) for seven days along with observation will result in improved hearing and balance function in individuals who demonstrate these disorders after blast exposure when compared to a placebo medicine and observation at the seven day time point.

Conditions

  • Mild Traumatic Brain Injury

Interventions

DRUG

N-acetyl-cysteine (NAC)

Anti-oxidant in a pill format

DRUG

Placebo

Control for study

Sponsors & Collaborators

  • Brooke Army Medical Center

    lead FED

Principal Investigators

  • Michael E. Hoffer, M.D. · U.S. Military

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-03-31
Completion
2009-08-31

Countries

  • Iraq

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822263 on ClinicalTrials.gov